News
FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...
Ticker: Americans putting money in investment income; FDA names former pharmaceutical company executive to oversee US drug ...
Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...
Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...
The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...
The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...
George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...
Top experts from Amgen, CBIZ & Intrepid discuss 2025 trends in healthcare, biotech, and life sciences. Explore key insights ...
And even after the significant gains it has experienced in recent years, it might still be early enough to get on the ...
Engineers at Georgia Tech developed a new mode of delivery for injectable medications — an 'exploding' capsule.
13h
All Penny Stocks (English) on MSNShares Of Micro Cap Biotech Surge After Breakthrough FDA Designation
Alzheimer’s disease impacts more than 6 million Americans and remains a significant public health challenge with few effective treatment options. Fortunately, a new development announced this morning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results